Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Beginners can start with a clear, low-risk entry into crypto. This intro explains selecting a primary asset, setting investment caps, and gradually expanding.
19,656 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A Michigan father received a frightening call about his son being in jail. He paid $5,500 with gift cards, unaware th...
NVIDIA earnings arrive with high volatility and big questions. This article breaks down the historical post-earnings ...
Spotting a strong real estate market isn’t guesswork. By watching a few proven metrics that matter: spot—rent growth,...
A fresh institutional stake has emerged in Victoria’s Secret stock this quarter. The $8.5 million bet suggests some m...
Major banks reduced price targets on Salesforce ahead of its Q4 earnings, sparking a broader debate about growth pros...
Bridger Management quietly exited a large Bath & Body Works position in the fourth quarter, selling about 301,000 sha...
As 2025 closes, star bulk (sblk) enters a new chapter. This guide breaks down the Q4 2025 results, fleet strategy, ba...
February delivered a chilly stretch for investors as inflation concerns and AI headlines weighed on stock prices. Thi...
A wave of money is moving beyond U.S. markets. International stock funds are pulling in large inflows, signaling a sh...
Capital moves matter. Capricorn Investment Group reduced its Navitas Semiconductor stake by about 1.19 million shares...
Broadcom stock rallied Thursday as AI-driven demand for semiconductor hardware pushed shares higher. This article bre...